Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 748-752

  El Zein, Randa ^a   Gu, Yun ^a   Sierra, Monica S ^a   Spitz, Margaret R ^a   Strom, Sara S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CHROMOSOME 1; CHROMOSOME BREAKAGE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; X CHROMOSOME;

AGED; CASE-CONTROL STUDIES; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, X; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 16844367598     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0236     Document Type: Article

References (52)

1. American Cancer Society. Cancer facts and figures. Atlanta (GA): American Cancer Society, Inc; 2004.
2. Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP. Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 1979;39:284-92.
3. Nowell PC. Mechanisms of tumor progression. Cancer Res 1986;46:2203-7.
4. Konig JJ, Teubel W, van Dongen JW, Hagemeijer A, Romijn JC, Schroder FH. Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chromosomes Cancer 1993;8:22-7.
5. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR. Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromosomes Cancer 1994;11:163-70.
6. Gibbs M, Stanford JL, McIndoe RA, et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999;64:776-87.
7. Giovannucci E, Stampfer MJ, Krithivas K, et al. The AG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 1997;94:3320-3.
8. Hardy DO, Scher HI, Bogenreider T, et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-5.
9. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-40.
10. Zucchi I, Jones J, Affer M, et al. Transcription map of Xq27: candidates for several X-linked diseases. Genomics 1999;57:209-18.
11. Smith JR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-4.
12. Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20:175-9.
13. Migeon BR, Brown TR, Axelman J, Migeon CJ. Studies of the locus for androgen receptor: localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse. Proc Natl Acad Sci U S A 1981;78:6339-43.
14. Verhagen PC, Hermans KG, Brok MO, et al. Deletion of chromosomal region 6ql4-16 in prostate cancer. Int J Cancer 2002;102:142-7.
15. Wolter H, Trijic D, Gottfried HW, Mattfeldt T. Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization. Eur Urol 2002;41:328-34.
16. Steiner T, Junker K, Burkhardt F, Braunsdorf A, Janitzky V, Schubert J. Gain in chromosome 8q correlates with early progression in hormonal treated prostate cancer. Eur Urol 2002;41:167-71.
17. Eastmond DA, Rupa DS, Hasegawa LS. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res 1994;322:9-20.
18. Rupa DS, Hasegawa L, Eastmond DA. Detection of chromosomal breakage in the 1cen-1q12 region of interphase human lymphocytes using multicolor fluorescence in situ hybridization with tandem DNA probes. Cancer Res 1995;55:640-5.
19. Conforti-Froes N, El-Zein R, Abdel-Rahman SZ, Zwischenberger JB, Au WW. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat Res 1997;379:53-9.
20. Smith LE, Grosovsky AJ. Genetic instability on chromosome 16 in a human B lymphoblastoid cell line. Somat Cell Mol Genet 1993;19:515-27.
21. Grosovsky AJ, Parks KK, Giver CR, Nelson SL. Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol Cell Biol 1996;16:6252-62.
22. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity of genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1998;43:403-9.
23. Sandberg AA. Chromosome abnormalities in human cancer and leukemia. Mutat Res 1991;247:231-40.
24. Solomon E, Borrow J, Goodard AD. Chromosome aberrations and cancer. Science 1991;254:1153-60.
25. Nordenson I, Beckman K, Liden S, Stjernberg N. Chromosomal aberrations and cancer risk. Hum Hered 1984;34:76-81.
26. Barrios L, Caballin MR, Miro R, et al. Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for chromosome Instability. Hum Genet 1988;78:320-4.
27. Barrios L, Miro R, Caballin MR, et al. Chromosome instability in bladder carcinoma patients. Cancer Genet Cytogenet 1990;49:107-11.
28. Madhavi R, Guntur M, Ghosh R, Ghosh PK. Double minute chromosomes in the leukocytes of a young girl with breast carcinoma. Cancer Genet Cytogenet 1990;44:203-7.
29. Bonassi S, Abbondandolo A. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Cancer Genet Cytogenet 1995;79:133-5.
30. Hagmar L, Brogger A, Hansteen IL, et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 1994;54:2919-22.
31. Hagmar L, Bonassi S, Stromberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998;58:4117-21.
32. Bonassi S, Hagmar L, Stromberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000;60:1619-25.
33. Rabinovitch PS, Dziadon S, Brentnall TA, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59:5148-53.
34. Hawkins NJ, Gorman P, Tomlinson IP, Bullpitt P, Ward RL. Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway. Am J Pathol 2000;157:385-92.
35. Williams AC, Miller JC, Collard T, Browne SJ, Newbold RF, Paraskeva C. The effect of different TP53 mutations on the chromosomal stability of a human colonic adenoma derived cell line with endogenous wild type TP53 activity, before and after DNA damage. Genes Chromosomes Cancer 1997;20:44-52.
36. Burt EC, James LA, Greaves MJ, Birch JM, Boyle LM, Varley JM. Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts. Br J Cancer 2000;83:467-72.
37. Dhillon VS, Dhillon IK. Chromosome aberrations and sister chromatid exchange studies in patients with prostate cancer: possible evidence of chromosome instability. Cancer Genet Cytogenet 1998;100:143-7.
38. Ozen M, Hopwbod VL, Balbay MD, et al. Correlation of non-random chromosomal aberrations in lymphocytes of prostate cancer patients with specific clinical parameters. Int J Oncol 2000 Jul;17:113-7.
39. Mitra AB, Murty W, Luthra UK. Sister chromatid exchanges in leukocytes of patients with cancer of cervix uteri. Hum Genet 1982;60:214-5.
40. Dhillon VS, Bhasker R, Kler RS, Husain SA. Sister chromatid exchange (SCE) studies in breast cancer patients: a follow-up study. Cancer Genet Cytogenet 1995;80:115-7.
41. Trapman J. Molecular mechanisms of prostate cancer. Eur J Cancer 2001;7:S119-25.
42. Imperato-McGinley J, Ip NY, Gautier T, et al. DNA linkage analysis and studies of the androgen receptor gene in a large kindred with complete androgen insensitivity. Am J Med Genet 1990;36:104-8.
43. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 1992;4:16-24.
44. Atkin NB, Baker MC. Chromosome study of five cancers of the prostate. Hum Genet 1985;70:359-64.
45. Casalone R, Portentoso P, Granata P, et al. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Cancer Genet Cytogenet 1993;68:126-30.
46. Vastag B. Genome analysis yields mutations linked to hereditary prostate cancer. JAMA 2002;287:827-8.
47. Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-4.
48. El-Zein R, Bondy ML, Wang LE, et al. Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas. Carcinogenesis 1999;20:811-5.
49. El-Zein R, Bondy ML, Wang LE, et al. Risk assessment for developing gliomas: a comparison of two Cytogenetic approaches. Mutat Res 2001;490:35-44.
50. Gaston KE, Kim D, Singh S, Ford OH, Mohler JL. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 2003;170:990-3.
51. Gong G, Oakley-Girvan I, Wu AH, et al. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002;13:471-82.
52. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.